QI
IMGN

QS Investors’s Immunogen Inc IMGN Stock Holding History

QS Investors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,200
Closed -$11K – 1593
2020
Q2 		$11K Hold
2,200
– – ﹤0.01% 1537
2020
Q1 		$8K Hold
2,200
– – ﹤0.01% 1547
2019
Q4 		$11K Hold
2,200
– – ﹤0.01% 1527
2019
Q3 		$6K Buy
+2,200
New +$5.84K ﹤0.01% 1596
2016
Q1 		– Sell
-21
Closed -$1K – 2082
2015
Q4 		$1K Buy
+21
New +$258 ﹤0.01% 1895

Other funds holding IMGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QS Investors's IMGN Position: Q3 2020 in Review

QS Investors sold out of Immunogen Inc (IMGN) in Q3 2020, closing a stake of 2,200 shares — an estimated $11K sold.

QS Investors first reported a position in IMGN in Q4 2015 and held it in 5 quarters. The position peaked at $11K in Q2 2020. 185 funds tracked by Wall St. Rank hold IMGN as of Q3 2020.

  • QS Investors reported no remaining Immunogen Inc position as of Q3 2020 after selling out during the quarter.
  • QS Investors sold 2,200 Immunogen Inc shares in Q3 2020, an estimated $11K.
  • QS Investors first reported a position in Immunogen Inc in Q4 2015 and held it in 5 quarters.
  • QS Investors's Immunogen Inc position peaked at $11K in Q2 2020.
  • 185 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2020.

Based on QS Investors's 13F filing for Q3 2020, filed 12 Nov 2020.